- Home
- NNN vs HALO Comparison
NNN vs HALO Comparison
Compare NNN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNN
- HALO
- Stock Information
- Founded
- NNN 1984
- HALO 1998
- Country
- NNN United States
- HALO United States
- Employees
- NNN N/A
- HALO N/A
- Industry
- NNN Real Estate Investment Trusts
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NNN Real Estate
- HALO Health Care
- Exchange
- NNN Nasdaq
- HALO Nasdaq
- Market Cap
- NNN 7.9B
- HALO 7.4B
- IPO Year
- NNN N/A
- HALO N/A
- Fundamental
- Price
- NNN $41.07
- HALO $53.75
- Analyst Decision
- NNN Hold
- HALO Buy
- Analyst Count
- NNN 11
- HALO 9
- Target Price
- NNN $44.60
- HALO $63.56
- AVG Volume (30 Days)
- NNN 1.0M
- HALO 3.3M
- Earning Date
- NNN 05-01-2025
- HALO 05-06-2025
- Dividend Yield
- NNN 5.66%
- HALO N/A
- EPS Growth
- NNN N/A
- HALO 55.40
- EPS
- NNN 2.14
- HALO 3.76
- Revenue
- NNN $884,713,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- NNN $4.43
- HALO $25.77
- Revenue Next Year
- NNN $4.26
- HALO $18.01
- P/E Ratio
- NNN $19.17
- HALO $14.29
- Revenue Growth
- NNN 5.40
- HALO 25.64
- 52 Week Low
- NNN $35.80
- HALO $42.01
- 52 Week High
- NNN $49.57
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- NNN 44.37
- HALO 42.85
- Support Level
- NNN $40.20
- HALO $52.43
- Resistance Level
- NNN $42.18
- HALO $54.26
- Average True Range (ATR)
- NNN 0.62
- HALO 3.37
- MACD
- NNN -0.06
- HALO -0.70
- Stochastic Oscillator
- NNN 24.57
- HALO 27.16
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.